Scarica l'app Stockscreener
84.36
0.58%
0.5022
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTVA Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$83.86
Aprire:
$83.99
Volume 24 ore:
257.79K
Relative Volume:
0.07
Capitalizzazione di mercato:
$56.46B
Reddito:
$17.89B
Utile/perdita netta:
$1.26B
Rapporto P/E:
49.54
EPS:
1.7029
Flusso di cassa netto:
$2.05B
1 W Prestazione:
-1.70%
1M Prestazione:
+13.28%
6M Prestazione:
+22.86%
1 anno Prestazione:
+12.72%
Intervallo 1D:
$83.23
$84.42
Intervallo di 1 settimana:
$83.23
$87.69
Portata 52W:
$60.53
$87.69
Corteva Inc Stock (CTVA) Company Profile
Nome
Corteva Inc
Settore
Industria
Telefono
(833) 267-8382
Indirizzo
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Compare CTVA vs NTR, CF, MOS, ICL
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTVA
Corteva Inc
|
84.42 | 56.09B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
64.59 | 31.00B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
114.55 | 17.52B | 7.41B | 2.12B | 1.62B | 11.13 |
MOS
Mosaic Company
|
21.40 | 6.60B | 12.05B | 575.40M | -534.60M | 1.6871 |
ICL
Icl Group Ltd
|
4.84 | 6.26B | 7.41B | 314.00M | 220.88M | 0.202 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-09 | Downgrade | UBS | Buy → Neutral |
| 2026-02-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-10-03 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-10-02 | Downgrade | Citigroup | Buy → Neutral |
| 2025-10-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-08-13 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-03-31 | Aggiornamento | Argus | Hold → Buy |
| 2025-03-13 | Iniziato | Goldman | Buy |
| 2024-10-23 | Iniziato | Citigroup | Buy |
| 2024-10-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-08-07 | Downgrade | Argus | Buy → Hold |
| 2024-04-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-03-01 | Iniziato | Wolfe Research | Outperform |
| 2024-02-12 | Aggiornamento | Loop Capital | Hold → Buy |
| 2024-02-02 | Aggiornamento | Exane BNP Paribas | Underperform → Neutral |
| 2023-11-27 | Downgrade | Berenberg | Buy → Hold |
| 2023-11-14 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-10-20 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-09-05 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-25 | Downgrade | Redburn | Buy → Neutral |
| 2023-06-28 | Iniziato | Canaccord Genuity | Buy |
| 2023-05-22 | Aggiornamento | Vertical Research | Hold → Buy |
| 2023-04-06 | Iniziato | Oppenheimer | Perform |
| 2023-01-19 | Iniziato | Wells Fargo | Overweight |
| 2023-01-11 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Downgrade | UBS | Buy → Neutral |
| 2022-11-15 | Downgrade | Loop Capital | Buy → Hold |
| 2022-08-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-08-08 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2022-07-14 | Iniziato | Credit Suisse | Outperform |
| 2022-06-01 | Iniziato | Barclays | Overweight |
| 2022-05-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-14 | Aggiornamento | Loop Capital | Hold → Buy |
| 2022-04-14 | Downgrade | Vertical Research | Buy → Hold |
| 2022-01-31 | Aggiornamento | Redburn | Neutral → Buy |
| 2021-10-18 | Downgrade | Loop Capital | Buy → Hold |
| 2021-10-13 | Iniziato | Mizuho | Buy |
| 2021-10-08 | Iniziato | ROTH Capital | Buy |
| 2021-09-01 | Iniziato | Berenberg | Buy |
| 2021-08-09 | Aggiornamento | Monness Crespi & Hardt | Sell → Neutral |
| 2021-05-10 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-04-19 | Aggiornamento | Loop Capital | Hold → Buy |
| 2021-02-05 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-02-05 | Reiterato | Monness Crespi & Hardt | Sell |
| 2020-12-18 | Downgrade | Susquehanna | Positive → Neutral |
| 2020-12-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-10 | Aggiornamento | Argus | Hold → Buy |
| 2020-10-19 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-10-19 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
| 2020-08-11 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-08-10 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-07-13 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2020-06-26 | Iniziato | Cleveland Research | Neutral |
| 2020-06-16 | Aggiornamento | Vertical Research | Hold → Buy |
| 2020-06-08 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
| 2020-05-11 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2020-04-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-04-17 | Aggiornamento | Loop Capital | Sell → Hold |
| 2020-04-01 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-31 | Aggiornamento | Susquehanna | Neutral → Positive |
| 2020-03-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-03-19 | Aggiornamento | Edward Jones | Hold → Buy |
| 2020-03-13 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-03-10 | Aggiornamento | Monness Crespi & Hardt | Sell → Neutral |
Mostra tutto
Corteva Inc Borsa (CTVA) Ultime notizie
Summit Securities Group LLC Buys 19,107 Shares of Corteva, Inc. $CTVA - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 197,471 Shares of Corteva, Inc. $CTVA - MarketBeat
FTC Can't Get Trial Scheduled Against Syngenta & Corteva - Law360
3rd Circ. Questions Standing In DuPont, Corteva Appeals - Law360
Corteva Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Basic Materials: Sector Rises but Underperforms, Leaving Opportunities in Chemicals and Agriculture - Morningstar
New York sues 3M, DuPont, Corteva and others over so-called forever chemicals - The Indiana Lawyer
Corteva stock trades steadily as crop protection and seed demand support the business - AD HOC NEWS
What to Expect From Corteva's Next Quarterly Earnings Report - Barchart.com
Corteva Inc. stock outperforms competitors despite losses on the day - MarketWatch
Corteva focuses on crop protection and seed innovation as a global agriculture pure play - Ad-hoc-news.de
Is AVO's Sustainable Growth Strategy Built for the Long Run? - TradingView
What Does Corteva's (NYSE:CTVA) Arevo Deal Mean for S&P 500? - Kalkine Media
Responsive Playbooks and the CTVA Inflection - Stock Traders Daily
Is Corteva (CTVA) Stock Rich Or Reasonable As Breakups Near? - Yahoo Finance
Price to sales forward of Corteva, Inc. – NYSE:CTVA - TradingView
Does Integrating Arginex Soy Into Seed Treatments Deepen Corteva’s Biologicals Strategy (CTVA)? - simplywall.st
How Adding Arginex Soy to Seed Treatments at Corteva (CTVA) Has Changed Its Investment Story - Yahoo Finance
Corteva and Arevo Partner on Soy Crop Nutrition - GlobeNewswire
Bronte Capital Management Pty Ltd. Has $42.09 Million Stock Position in Corteva, Inc. $CTVA - MarketBeat
CTVACorteva Inc Volatility & Greeks - Finviz
Mizuho Securities Maintains Corteva(CTVA.US) With Buy Rating, Raises Target Price to $96 - Moomoo
Rimisoxafen herbicide technology announced by two companies - High Plains Journal
Corteva stock hits all-time high at 85.64 USD - Investing.com UK
Corteva stock hits all-time high at 85.64 USD By Investing.com - Investing.com Australia
Pesticide Giant Syngenta Appoints New CEO - marketscreener.com
Farm Hands on the Potomac: Olivia Bridges joins Agri-Pulse team, Corteva announces boards of directors, Donna Garren appointed to FDA role - Agri-Pulse
Corteva names boards of directors for new crop protection and seed companies - Indianapolis Business Journal
Corteva Inc. stock outperforms competitors on strong trading day - MarketWatch
Vylor Names Seven-Person Board Led by Karen Grimes Ahead of Corteva Separation - iGrow News
Disruption in the Agricultural Sector: Why Corteva and Deere & Company Are Keeping an Eye on MustGrow Biologics - news.financial
Corteva names board for crop protection spinoff - Investing.com UK
Corteva (CTVA) Announces Board Resignations Ahead of Seed Busine - GuruFocus
Corteva Details Board for Future Crop Protection Spinoff - TipRanks
Corteva names board for crop protection spinoff By Investing.com - Investing.com Australia
Karen Grimes, Marcos Lutz, Charles Magro and Kerry Preete to Resign from Corteva Board Ahead of Vylor Spin-Off - TradingView
Corteva (CTVA) details Corteva and Vylor boards as 4Q 2026 spin-off nears - Stock Titan
Corteva Announces Board of Directors for Advanced Seed and Genetics Spin-Off Vylor - PR Newswire
Citigroup maintains Corteva (CTVA) neutral recommendation - MSN
Corteva, Inc.(NYSE: CTVA) dropped from Russell 1000 Dynamic Index - marketscreener.com
Enterprise value to EBIT forward of Corteva, Inc. – NYSE:CTVA - TradingView
FMC and Corteva partner to expand access to Rimisoxafen technology - MSN
How Investors May Respond To Corteva (CTVA) Rimisoxafen Supply Deal And US$200 Million Prepurchase - simplywall.st
Corteva Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
CTVA Technical Analysis & Stock Price Forecast - Intellectia AI
Price to earnings forward of Corteva, Inc. – NYSE:CTVA - TradingView
Corteva Stock And Other Pesticide Names Getting Relief From Supreme Court Lawsuit Limits - Sahm
Price to sales forward of Corteva, Inc. – BOATS:CTVA - TradingView
Corteva Shares Rise Following Landmark Supreme Court Pesticide Ruling - Sahm
Price to earnings forward of Corteva, Inc. – BOATS:CTVA - TradingView
Enterprise value to EBIT forward of Corteva, Inc. – BOATS:CTVA - TradingView
Corteva Inc Azioni (CTVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.20%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):